The API Innovation Center gained recognition on Nine PBS for our efforts in relocating the manufacturing of vital medications back to the United States. Recently highlighted on the St. Louis network, our center demonstrated its commitment to establishing reliable and eco-friendly pathways for producing critical drugs within the U.S. During Anthony Sardella’s interview, he elaborated on the center’s mission to bolster national health security by fostering active pharmaceutical ingredient (API) production in the St. Louis area. Watch the complete interview for further insights.